So if we based our valuation on FCF calculated as NPAT + D&A - CapEx
FCF for 12/20 - 12/21 =
NPAT - $15m
D&A - $9M
CapEx - $3.7m (ex. one off PP&E purchase)
FCF = $20m
EV / FCF = 203 / 20 = 10x
FCF Yield = 9.8%
This excludes PFA acquisition which will be greatly accretive to FCF given the recurring revenues & low CapEx model.
Let's now include PFA & assume it executes on it's earn out & achieves $6m EBITDA & $5m NPAT in FY22
Genus FY22 Financials Estimated:
EBITDA = $43m
D&A - $10-$13m
EBIT - $30m
Interest - $2m
Tax @ 30% - $9m
NPAT - $19m + $5m FPA = $24m
FY22 FCF
NPAT - $24 +
D&A - $13 -
CapEx - $16m (incl. one off purchase of $6m PP&E for FMG transmission project) normalized CapEx is $10m approx.
FCF = $21m
FCF normalized = $27m
FCF Yield = 10.5%
Normalized = 13%
- Forums
- ASX - By Stock
- Ann: Half Yearly Report and Accounts
GNP
genusplus group ltd
Add to My Watchlist
2.28%
!
$3.59

So if we based our valuation on FCF calculated as NPAT + D&A -...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$3.59 |
Change
0.080(2.28%) |
Mkt cap ! $646.8M |
Open | High | Low | Value | Volume |
$3.54 | $3.59 | $3.48 | $113.8K | 32.34K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 759 | $3.56 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.59 | 551 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 832 | 3.560 |
3 | 1206 | 3.550 |
2 | 1734 | 3.540 |
3 | 3876 | 3.530 |
2 | 105 | 3.520 |
Price($) | Vol. | No. |
---|---|---|
3.590 | 551 | 3 |
3.600 | 1149 | 2 |
3.610 | 1171 | 2 |
3.620 | 797 | 2 |
3.630 | 869 | 2 |
Last trade - 14.12pm 20/06/2025 (20 minute delay) ? |
Featured News
GNP (ASX) Chart |